H.B. Fuller (NYSE:FUL) Sets New 52-Week Low – Time to Sell?

H.B. Fuller (NYSE:FUL)’s stock price hit a new 52-week low during trading on Wednesday . The company traded as low as $54.00 and last traded at $54.07, with a volume of 88868 shares changing hands. The stock had previously closed at $55.57.

Analysts Set New Price Targets

Several research firms have recently weighed in on FUL. Vertical Research lowered H.B. Fuller from a “buy” rating to a “hold” rating in a research note on Monday, January 6th. Deutsche Bank Aktiengesellschaft decreased their price target on H.B. Fuller from $75.00 to $72.00 and set a “buy” rating for the company in a research report on Wednesday, January 22nd. Seaport Res Ptn cut H.B. Fuller from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 5th. JPMorgan Chase & Co. reduced their price objective on shares of H.B. Fuller from $70.00 to $60.00 and set an “underweight” rating for the company in a research note on Friday, January 17th. Finally, Citigroup decreased their target price on shares of H.B. Fuller from $78.00 to $68.00 and set a “neutral” rating for the company in a report on Friday, January 3rd. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $75.60.

H.B. Fuller Stock Down 2.8 %

The stock has a market capitalization of $2.93 billion, a price-to-earnings ratio of 23.44, a price-to-earnings-growth ratio of 1.13 and a beta of 1.41. The company has a quick ratio of 1.16, a current ratio of 1.81 and a debt-to-equity ratio of 1.10. The firm has a 50-day moving average of $60.66 and a two-hundred day moving average of $71.16.

H.B. Fuller (NYSE:FUL) last released its earnings results on Wednesday, January 15th. The specialty chemicals company reported $0.92 earnings per share for the quarter, missing the consensus estimate of $1.00 by ($0.08). The business had revenue of $923.00 million for the quarter, compared to analysts’ expectations of $916.84 million. H.B. Fuller had a net margin of 3.65% and a return on equity of 12.01%. The company’s revenue was up 2.2% compared to the same quarter last year. During the same period last year, the firm earned $1.32 EPS. As a group, sell-side analysts anticipate that H.B. Fuller will post 4.07 earnings per share for the current year.

H.B. Fuller Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, February 20th. Shareholders of record on Thursday, February 6th were paid a $0.2225 dividend. The ex-dividend date of this dividend was Thursday, February 6th. This represents a $0.89 annualized dividend and a yield of 1.65%. H.B. Fuller’s dividend payout ratio is presently 38.53%.

Institutional Investors Weigh In On H.B. Fuller

A number of institutional investors have recently modified their holdings of the stock. Jones Financial Companies Lllp raised its holdings in shares of H.B. Fuller by 128.8% during the fourth quarter. Jones Financial Companies Lllp now owns 899 shares of the specialty chemicals company’s stock worth $61,000 after acquiring an additional 506 shares in the last quarter. Sterling Capital Management LLC increased its position in H.B. Fuller by 731.1% in the 4th quarter. Sterling Capital Management LLC now owns 1,255 shares of the specialty chemicals company’s stock worth $85,000 after purchasing an additional 1,104 shares during the last quarter. Quantbot Technologies LP purchased a new stake in shares of H.B. Fuller during the 4th quarter worth about $266,000. New Age Alpha Advisors LLC purchased a new stake in shares of H.B. Fuller during the 4th quarter worth about $465,000. Finally, KLP Kapitalforvaltning AS acquired a new stake in shares of H.B. Fuller during the 4th quarter valued at about $783,000. Institutional investors and hedge funds own 95.93% of the company’s stock.

H.B. Fuller Company Profile

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.